Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However, several issues need revisiting, including the criteria for identification of BCR stereotypy and its actual frequency as well as the identification of "CLL-biased" features in BCR Ig stereotypes. To this end, we examined 7596 Ig VH (IGHV-IGHD-IGHJ) sequences from 7424 CLL patients, 3 times the size of the largest published series, with an updated version of our purpose-built clustering algorithm. We document that CLL may be subdivided into 2 distinct categories: one with stereotyped and the other with nonstereotyped BCRs, at an approximate ratio of 1: 2, and provide ...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subset...
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subset...
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (qu...
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (qu...
Chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor (BCR) belonging to subset #1 (IG...
Chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor (BCR) belonging to subset #1 (IG...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
Background About 30% of cases of chronic lymphocytic leukaemia (CLL) carry quasi-identical B-cell re...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subset...
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subset...
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (qu...
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (qu...
Chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor (BCR) belonging to subset #1 (IG...
Chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor (BCR) belonging to subset #1 (IG...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BC...
Background About 30% of cases of chronic lymphocytic leukaemia (CLL) carry quasi-identical B-cell re...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...
Abstract Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chro...
Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocyti...